Sponsor Pipeline

Inhibikase Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
2
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07365332 An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH) Pulmonary Arterial Hypertension Recruiting
NCT07632898 Open-Label Study of IKT-001 in Pulmonary Arterial Hypertension (PAH) Pulmonary Arterial Hypertension (PAH) Not Yet Recruiting
Disease Areas
Hypertension (2)
Get alerts when Inhibikase Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free